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in all hearts from the onset of the PC/control period (n = 6 per group)
and terminated 2.5 min prior to CO. Coronary flow and LV pressure were
monitored throughout each protocol, and area of necrosis (AN)was assessed
by tetrazolium staining and expressed as a % of the area at risk of infarction
(AR).
ANIAR
Protocol1: Control 63 l 2%
Pc 30+ 6%**
Protocol2: Control+’Neomycin 56+ 10%
PC+ Neomycin 54* 9%
Protocol 1 confirmed the expected reduction in infarct size in PC hearts
versus controls (** p < 0.01). In contrast, in Protocol 2, infarct size was com-
parable in both control and PC hearts treated with neomycin. Impotiantly,
protection with PC - and loss of protection with neomycin - was not due to
differences in coronary flow or LV pressure among groups (data not shown).
These results support the concept that activation of the second messenger
inositol (1,4,5)-trisphosphate (and subsequent release of calcium from intra-
cellular stores) during brief antecedent ischemisJreperfusionis an important
mediator of infarct size reduction with preconditioning in this isolated rabbit
heart model.
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infsrotion: Interaction between age and right
ventricular infarction
H. Bueno, R. Lopez-Palop, J. Osende, J. Garcfa-Garcia, E. Perez-David,
J.A. Serrano, J.L. Lopez-SendOn,J.L. Delcan. Hospital General Gregorio
Marafin6n, Madrid, Spain
Itis known that patients with acute inferior myocerdial infarction (lMl) and
right ventricular infarction (RVI) have a worse prognosis than those without it
and that the elderly also have a poorer outcome. To assess the influence of
age on prognosis of IMI and its relation with RVI, we studied the in-hospital
clinical outcome of 652 consecutive patients admitted to our CCU with a
definite diagnosis of IMI of less of 46 hours of evolution and compared their
outcomes according to their age and to the presence of RVI.
Resu/ts.’Themean ageofthewhole groupwa.s73+ 13years, 80% males.
Thrombolysis was used in 47% of patients and primary PTCA in 3%. The
incidence of RVI was 35%. The total in-hospital mortality rate was 12% (20Y0
inpatients with RVI, 5% in those without, p < 0.001). A significant (p < 0.001)
mrrelation between age and mortality was found in both groups. The addition
of the interaction factor RV1-ageto the logistic regression model was only
significant in patients older than 65 year. We plotted age and mortality (Fig.)
and found an exponential increase in mortality which was only significant in
patients older than 65 years with RVI (logistic regression coefficient D:0.152,
p <0.0005. In patients without RVI, ~: 0.021, p < 0.55).
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Conclusion: The in-hospital mortality of IMI is age-dependent, but this
dependence is essentially related to the precence of RVI.
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El7772 Non-Q wave myocardial infarction ia notindapandently associated with worsa outcome in the
aldarly
J.E. Murillo, J. Chen, 0. Jagasia, Y. Wang, H.M. Krumholz. YaleUrriversity
School ofhfedicirre, NewHaven, CT USA
Several studies, predominately of younger patient.s,suggeat that non-Q wave
myocardial infarction (NQWMI) has a better in-hospital outcome than Q-
wave myccerdial infarction (QWMI), but the advantage is lost over time.
To determine the association of NQWMI with outcome in the elderly, we
used the Connecticut cohort of the Cooperative Cardiovascular Project pilot
datebase which contains medical record information for Medicare patients
admitted with acute myocardial infarction (Ml). Both admission and discharge
electrocardiograms were interpreted to classify patients by the presence of
Q waves,
Among the 2,720 patients >65 years with interpretable electrocardio-
grams, 1,533 patients (56%) had an NQWMI. Patients with NQWMI had a
significantly lower in-hoepital mortality rate than QWMI (12% vs. 19%, P <
0.001). Among the 2,309 patients who survived the hospitalization, 1,350
(58%) had a NQWMI. These patients were significantly older and more likely
to have a history of Ml, CHF, diabetes, afid revascularization surgety. The
rate of cath during the initial hospitalization was 36% for the two groups. Dur-
ing the year after discharge, NQWMI patients had a mortality rate that was
not significantly different from QWMI patients (20% vs. 17%, respectively,
P = 0.12). After adjusting for demographic, clinical, pharmacological, and
electrocardiographic variables, and treatment, NQWMI was not associated
with any increased risk mmpared with QWMI (OR 0.89, 95% Cl 0.68 to
1,15, P value 0.37). The rate of readmission for any cause during the year
postdischarge was also not different for both groups: 50.6% for QWMI and
50.3% for NQWMI.
Conclusion: Among elderly hospital survivors of AMI, NQWMI does not
predict higher one-year mortality or one-year readmission when compared
to QWMI.
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~[ RagiOnalvariatiOn inmYOcardialinfarc~iOn care:~he
cooperative cardiovascular project experience
T,A. Marciniak, H.M. Krumholz. Health Care FirrarrcingAdrrrirristration,
Baltimore, MD, and Ya/aUrriversifySchool of Medicine, New Haven, CT
USA
The Health Care Financing Administration’s Cooperative Cardiovascular
Project abstracted 224,377 medical records of hospital discharges of Medi-
care patients with acute myocardial infarction (AMI) from February, 1994,
through July, 1995. These data show significant variations in care processes
and outcomes acrossthe nation when the data are analyzed by the nine Cen-
sus Bureau regions. The most striking variations are lower use of invasive
procedures in the New England region (angiography 22Y0,angioplasty 8Y.,
CABG 6%) and greater use of beta blockers at discharge (55%) compared
to the national means (angiography 36%, angioplasty 14’%.,CABG 9%, beta
blockars 39%). The variations in rates for other process measures are smaller
and more randomly distributed: reperfusion in ideal candidates (mean 66%,
range 59 to 74%); aspirin during the stay (mean 79%, range 77 to 82%) and
at discharge (mean 67%, range 65 to 71Yo); and ACE inhibitor use (mean
56%, range 52 to 64%) and calcium channel blocker avoidance (mean 64%,
range 81 to 87Yo)at discharge in patients with reduced LVEF. The 30-day
mortality rate is lowest in the New England region (15.3%), compared to the
national mean of 17.8%,and the survival advantage in New England persists
after risk adjustment (relative risk 0.8). Conclusion: Regional variations in




associated with selection for catheterization
following acute myocardial infarction
P.J. Higgins, D.E. Wennberg, T.J. Ryan, Jr.,C.T. Lambrew, W.J. French for
the Participants in the National Registry of Myocardial Infarction. Maine
Medical Center, Portland, MEand Hatior-UCLA, Torrance, CA, USA
Following acute Ml, pts ?80 yrs undergo cardiac catheterization (cath) less
frequently than younger pts yet have a higher overall mortality. To under-
stand post Ml decision making and resource utilization in octogenarians we
analyzed 21,354 pts ?80 yrs from the NRMI-2 regist!y admitted with Ml to
hospitals with cath facilities in the US from 11/94-1/96. Univariate and mul-
tivariate logistic regression analyses were used to assess for independent
associations with post Ml cath.
Multivariataoddsratiosfor postMl cath
Positive OR (950/0Cl) Negative OR (95”/0Cl)
PriorPTCA 1.9 (1.7, 2.3) PriorMl 0.9 (0.8, 0.99)
PriorCABG 1.3 (1.2. 1.5) PriorCHF 0.6 (0,5, 0,7)
Male Gender 1.3 ~1.2; 1.4j PriorCVA 0.6 (0.5; o.7j
RecurrentAngina 2.1 (1,9, 2.4) Shock 0.S (0.6, 0.9)
RecurrentMl 1,2 (1.01, 1.5) Hypotension 0.8 (0.7, 0,9)
ThrombelyticRx 1.3 (1.2, 1.5) CHF 0.9 (0,8, 0,99)
SBP ? 90 mmHg 1.7 (1,3, 2,2) New England 0.5 (0.4, 0.7)
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Cone/usion:This study of a large number of Ml pta ?80 yra suggeats that
pts at higher risk for one year mortality are Iesa likely to undergo post Ml
catheterization, while male pts, those with recurrent aymptoms and with prior
interventions are more likely to undergo cath. Presentation to a hospital in
New England haa a strong negative association with oath compared to the
rest of the country.
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n7775 Post-Ml testing in the elderly: Results in 190,135petients
E.D. Peterson, J.G. Jollis, J.A. Stafford, E.R. DeLong, L.H. Muhlbaier,
L.J. Shaw, D.B. Mark. Duke University Medical CerrteLDurham, NC, USA
National guidelines have suggested that post-Ml risk stratification should
include an aesesament of underlying mronary disease (CAD) severity and
left ventricular function. It ia unclear, however, whether these guidelines are
followed in the elderly. Uaing National Medicare Date (Parl A and B files),
we examined the use of non-invasive atreas tests (NIST), echocardiography
(Echo) and catheterization (Cath) during the first 80 daya following Ml in
190,135 patients aged ?65 admitted between 1/92 and 11/92.The median
age was 78.8 yre, 50.4% were women. Overall 30-day mortality rate was
21.2%, ranging from 12% in thoae 85-S9 yre to 47% for those ?80 yrs. At
Ieaat one NIST waa performed in 22% of patients, 54% had Echo and 35%
underwent Cath. Asseaament of CAD risk (Cath or NIST) occurred in 44%
and 68% had a quantitative measurement of LVEF (Echo, Cath or MUGA).
Patterns of post-Ml care by age group are displayed below:
Age Group(n) NIST Echo Cath Assess CAD Risk Measure LVEF
(“A) (“’4) (“/0) (%) (“A)
65-69 (37,994) 36 54 57 69 79
70-74 (44,398) 29 55 47 59 75
75-79 (42,459) 22 56 35 46 69
?80 (65,286) 10 51 12 19 57
Cone/usion:Despitefacin9 high post-Ml mortality risks,the use of invasive
and noninvasive teating for post-Ml risk stratification declined markedly with
advancing patient age. In particular, a LVEF waa flOt measured in over 40%
of octogenarian while over 80% had no formal assessment of CAD risk.
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myocerdial perfusion SPECT in the very elderly
A.M. Amanullah, R. Hachamovitch, J. Erel, J. Friedman, H. Lewin,
D.S. Berman. Cedara-Sinai Medicai Ctc L.A., CA, USA
Little ia known regarding the enhanced risk stratification of the very elderly
using myocardial perfusion imaging. Thua, we studied 873 consecutive pta
age ?80 years who underwent dual isotope myocerdial perfusion SPECT
(DIMPS) (rest T1-201/stressTc-99m sestamibi). 49 pts were Ioat to foliow-
UP(F/U) and 58 pta had early revascularizatiofl (S w days after DIMPS).
The remaining 766 pte (age: 83+3 years; exercise IEx~adenosine [Aden]:
381/405) were F/U for at least 1 year (mean 20+8 months) for hard events
(HE) [cardiac death (CD) or non-fatal Ml]. DIMPS was visually assessed
using 20 SPECT aegmente and a 5 point acoring system (O= normal, 4 =
absent uptake) from which aummed streas score (SSS), summed rest score
(SRS) and aummad reversibility or difference (SDS) score were calculated.
At F/U 83 HE occurred (Ex: CD = 17, nonfatal Ml = 12; Aden: CD = 43,
nonfatal Ml = 11). HE rates in Ex were 8% compared to 13% for Aden (p <
0.02). HE rates in pte with normal or mildly abnormal (SSS ? 8) scans were
4% (9/228) in Ex and 5% (11/215) in Aden, compared to 14.8% (20/135) in
Ex and 22.6% (4W190) in Aden for pts with severely abnormal scans (SSS
< 8) (p <0.001 for both). By a stepwise Cox proportional hazards model of
prescan variables, age and,exercise duration yielded aignificent information
(% = 5.4 and% = 18.7) in Ex, and age and history of Ml in Aden (~ =
6.6 and % = 7.3). For Ex, SDS added significant futther information after
“forcing in” the prescan variables (% = 39.4, gain in ~, p c 0.001). For
Aden, SSS added incremental information (% = 38.4, gain in J@,p < 0.001).
Conclusions: Among pts age ?80 yeare with an overall high HE rate, Ex
or Aden DIMPS added significant incremental prognostic information over





~] Clini~alSignifi~an~eof ~eurological Events
Associated with Carotid Stenting
S.S. Iyer, G. Roubin, S. Yadav,A. Mathur, C. Gomez, J.M. Parks, G. Yates,
K. Kretzer,J, Vitek. The University of A/abarna at Birmingham, Birmingham,
AL, USA
To determine the clinical significance of neurological events associated with
carotid stenting the prospectively recorded procedure complications in a
consecutive seriea of patients undergoing protocol conforming percutaneous
(femoral approach) carotid stent placement procedures were analyzed. One
off protocol death, one past procedure contralateral cardiogenic embolic
stroke and TIA’s were excluded. Between 9/94 and 8/96, 180 pts underwent
carotid atenting using both balloon expandable (BE), (95 pte, 111 veasels)
and self expanding (SE) (85 pts, 101 vessela). Definitions of neurological
events using change in NIH Stroke Scale and time to resolution together with
occurrence of these events are shown below.
Minimsl Neuro Deficit Minor Stroke Major Stroke
NIH Stroke Sale Chamae o-1 2-3 or ?4&
Deficit Resolution (days~ 57 530 >30
111 vessels with BE stents 5 2 1
101 vessels with SE stents 3 4 0
Total: 212 vessels 8 (3.80/’) 6 (2.8”/0) 1 (0.4%)
Two of six patients with minor strokes returned to baaeline within seven
days.
Conclusion: The incidence of neurological events following carotid stent-
ing ia acceptably low. Approximately half the events are minimal deficits, the
majority resolve within seven days.
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~778-2\proceduralR*u,tsandEar,Y~,inica,~utcomes
After Carotid Stent-Supported Angioplasty in
High-Risk Patients
JR. Laird, L.F.Satler, J.J. Popma, G.S. Mintz, A.J. Lensky, K. Horton,
S. Cabellon, R. Deible, R. Mehran, N. Prunka, M.B. Leon. Washington
Hospital Centec Washington, DC, USA
Catheter-based therapies for the treatment of extra-cranial carotid artery
diaease may be especially appropriate in patients who are at high risk for
complications from carotid endarterectomy (CEA). We performed 32 carotid
stent-supported angioplasty (CSSA) procedures in 30 patients with balloon
expandable tubular slotted stents. High risk patient characteristics included
significant coronary artery disease in 777., left ventricular dysfunction (LVEF
c 45%) in 30%, age >60 in 17%, and other co-morbid conditions (prior
CEA, COPD, A Fib, etc.) in 37%. Procedural success was achieved in
31 (97%) procedures. There was one procedural failure due to aortic arch
tortuosity. Quantitative angiography was performed using standard edge
detection techniques.
Baseline Final
Distal reference (mm) 4.62 + 0.89 4.82 & 0.80
Minimal lumen diameter (mm) 1.72 + 0.69 4,42 & 0.79
% Diameter stenosia ‘ 63& 14 8*12
There were no major angiographic complications. A proximal edge dis-
section occurred in one case (3%) requiring additional stenta. Two patients
(6%) experienced aperi-procedural minor atroke with resolution of symptoms
within one week. There were no procedure related deaths, M1’aor major
atrokes. One patient (3%) died within 30 days from an unrelated cause.
In conclusion: early experience with CSSA in high-risk patients is favor-
able with high technical/angiographic success and infrequent early clinical
events.
